The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center
Open accessAbstract
Objective: Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. Herein, we describe the clinical features and outcomes for a large series of ACC patients. Design and methods: Retrospective review of ACC patients seen at The University of Texas MD Anderson Cancer Center from 1998 through 2011. Results: A total of 330 patients with median age at diagnosis of 48.5 years; 12 (3.6%) patients were under 18 years. Hormonally functioning tumors represented 41.8% (n=138) of all cases. Surgical resection for the primary tumor was done in 275 (83.3%) patients (45 at MD Anderson (16.4%)). For those who had surgical resection, the median local-recurrence-free time was 1.04 years. Factors associated with local recurrence included positive surgical margins (P=0.007) and advanced disease stage (P=0.026). Median overall survival time for all patients was 3.21 years. Median survival times were 24.1, 6.08, 3.47, and 0.89 years for stages I, II, III, and IV respectively. In multivariable analysis, older age, functioning tumors, and higher disease stage remained significant prognostic factors associated with poor survival. Conclusion: ACC prognosis remains poor with the use of currently available treatments. Older age, functioning tumors, and incomplete resections are clinical factors associated with poor survival. Surgical expertise is important to achieve complete resections and to improve outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Identification and characterization of the familial adenomatous polyposis coli gene
Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M., et al. (1991) · Cell · doi:10.1016/0092-8674(81)90021-0 · Cited by 2,796
NEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
Shiloach, M., Frencher, S. K., Steeger, J. E., Rowell, K. S., Bartzokis, K., Tomeh, M. G., Richards, K. E., Ko, C. Y., & Hall, B. L. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.09.031 · Cited by 1,306
Pathology and genetics of tumours of endocrine organs
DeLellis, R. A. (2004) · Cited by 1,122
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Fassnacht, M., Terzolo, M., Allolio, B., Baudin, E., Haak, H., Berruti, A., Welin, S., Schade-Brittinger, C., Lacroix, A., Jarzab, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200966 · Cited by 873
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Fassnacht, M., Daffara, F., Tauchmanova, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 764
Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors
Bilimoria, K. Y., Shen, W. T., Elaraj, D., Bentrem, D. J., Winchester, D. J., Kebebew, E., & Sturgeon, C. (2008) · Cancer · doi:10.1002/cncr.23886 · Cited by 493
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474
Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435
GermlineTP53 mutations and Li-Fraumeni syndrome
Varley, J. M. (2003) · Human Mutation · doi:10.1002/humu.10185 · Cited by 430
Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome
Weksberg, R., Ren Shen, D., Ling Fei, Y., Li Song, Q., & Squire, J. (1993) · Nature Genetics · doi:10.1038/ng1093-143 · Cited by 424
Management of patients with adrenal cancer: recommendations of an international consensus conference
Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01029 · Cited by 421
An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome
Hatada, I., Ohashi, H., Fukushima, Y., Kaneko, Y., Inoue, M., Komoto, Y., Okada, A., Ohishi, S., Nabetani, A., Morisaki, H., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-171 · Cited by 382
Schulick, R. D., & Brennan, M. F. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0719-7 · Cited by 366
Kerkhofs, T. M. A., Verhoeven, R. H. A., Van der Zwan, J. M., Dieleman, J., Kerstens, M. N., Links, T. P., Van de Poll-Franse, L. V., & Haak, H. R. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.034 · Cited by 341
An eleven-year experience with adrenocortical carcinoma.
Pommier, R. F., & Brennan, M. F. (1992) · PubMed · Cited by 332
Haak, H., Hermans, J., van de Velde, C., Lentjes, E., Goslings, B., Fleuren, G.-J., & Krans, H. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.183 · Cited by 329
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
Stojadinovic, A., Ghossein, R. A., Hoos, A., Nissan, A., Marshall, D., Dudas, M. E., Cordon‐Cardo, C., Jaques, D. P., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.941 · Cited by 312
Hutter, A. M., & Kayhoe, D. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90220-8 · Cited by 271
Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors
Varley, J. M., McGown, G., Thorncroft, M., James, L. A., Margison, G. P., Forster, G., Evans, D. G. R., Harris, M., Kelsey, A. M., & Birch, J. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302575 · Cited by 266
Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients
Didolkar, M. S., Bescher, R. A., Elias, E. G., & Moore, R. H. (1981) · Cancer · doi:10.1002/1097-0142(19810501)47:9<2153::aid-cncr2820470908>3.0.co;2-6 · Cited by 244
Lughezzani, G., Sun, M., Perrotte, P., Jeldres, C., Alasker, A., Isbarn, H., Budäus, L., Shariat, S. F., Guazzoni, G., Montorsi, F., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.007 · Cited by 215
Gicquel, C., Raffin-Sanson, M.-L., Gaston, V., Bertagna, X., Plouin, P.-F., Schlumberger, M., Louvel, A., Luton, J.-P., & Le Bouc, Y. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4170 · Cited by 213
Bellantone, R., Ferrante, A., Boscherini, M., Lombardi, C. P., Crucitti, P., Crucitti, F., Favia, G., Borrelli, D., Boffi, L., Capussotti, L., et al. (1997) · Surgery · doi:10.1016/s0039-6060(97)90229-4 · Cited by 210
Hutter, M. M., Rowell, K. S., Devaney, L. A., Sokal, S. M., Warshaw, A. L., Abbott, W. M., & Hodin, R. A. (2006) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.07.010 · Cited by 197
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
Özata, D. M., Caramuta, S., Velázquez-Fernández, D., Akçakaya, P., Xie, H., Höög, A., Zedenius, J., Bäckdahl, M., Larsson, C., & Lui, W.-O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0082 · Cited by 191
Radiotherapy in adrenocortical carcinoma
Polat, B., Fassnacht, M., Pfreundner, L., Guckenberger, M., Bratengeier, K., Johanssen, S., Kenn, W., Hahner, S., Allolio, B., & Flentje, M. (2009) · Cancer · doi:10.1002/cncr.24331 · Cited by 189
Adrenal cortical carcinoma a study of 77 cases
Nader, S., Hickey, R. C., Sellin, R. V., & Samaan, N. A. (1983) · Cancer · doi:10.1002/1097-0142(19830815)52:4<707::aid-cncr2820520424>3.0.co;2-n · Cited by 184
Gicquel, C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.8.2559 · Cited by 184
Heaton, J. H., Wood, M. A., Kim, A. C., Lima, L. O., Barlaskar, F. M., Almeida, M. Q., Fragoso, M. C. B. V., Kuick, R., Lerario, A. M., Simon, D. P., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.05.026 · Cited by 173
Adrenocortical carcinoma: Clinical outcome at the end of the 20th century
Vassilopoulou-Sellin, R., & Schultz, P. N. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1113::aid-cncr1428>3.0.co;2-i · Cited by 160
Self-citationGrubbs, E. G., Callender, G. G., Xing, Y., Perrier, N. D., Evans, D. B., Phan, A. T., & Lee, J. E. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0716-x · Cited by 158
The role of surgery in the management of recurrent adrenocortical carcinoma
Erdogan, I., Deutschbein, T., Jurowich, C., Kroiss, M., Ronchi, C., Quinkler, M., Waldmann, J., Willenberg, H. S., Beuschlein, F., Fottner, C., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2559 · Cited by 154
Soon, P., Gill, A. J., Benn, D. E., Clarkson, A., Robinson, B. G., McDonald, K. L., & Sidhu, S. B. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0237 · Cited by 149
Naing, A., LoRusso, P. M., Fu, S., Hong, D. S., Chen, H. X., Doyle, L. A., Phan, A. T., Habra, M. A., & Kurzrock, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.46 · Cited by 147
Self-citationAdrenocortical Carcinoma: Surgical Progress or Status Quo?
Kendrick, M. L. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.5.543 · Cited by 142
MORIMOTO, R., SATOH, F., MURAKAMI, O., SUZUKI, T., ABE, T., TANEMOTO, M., ABE, M., URUNO, A., ISHIDOYA, S., ARAI, Y., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07-079 · Cited by 141
Cooper, A. B., Habra, M. A., Grubbs, E. G., Bednarski, B. K., Ying, A. K., Perrier, N. D., Lee, J. E., & Aloia, T. A. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-3034-0 · Cited by 123
Self-citationSurgical management, DNA content, and patient survival in adrenal cortical carcinoma
Lee, J. E., Berger, D. H., El‐Naggar, A. K., Hickey, R. C., Vassilopoulou‐Sellin, R., Gagel, R. F., Burgess, M. A., & Evans, D. B. (1995) · Surgery · doi:10.1016/s0039-6060(05)80119-9 · Cited by 115
Self-citationAdrenal cortical carcinoma in Norway, 1970–1984
Søreide, J. A., Brabrand, K., & Thoresen, S. (1992) · World Journal of Surgery · doi:10.1007/bf02067349 · Cited by 109
Hench, P. S., Slocumb, C. H., Barnes, A. R., Smith, H. L., Polley, H. F., & Kendall, E. C. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)08438-1 · Cited by 106
Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors
Terzolo, M., Boccuzzi, A., Bovio, S., Cappia, S., Giuli, P. D., Alì, A., Paccotti, P., Porpiglia, F., Fontana, D., & Angeli, A. (2001) · Urology · doi:10.1016/s0090-4295(00)00852-9 · Cited by 103
Habra, M. A., Ejaz, S., Feng, L., Das, P., Deniz, F., Grubbs, E. G., Phan, A., Waguespack, S. G., Ayala-Ramirez, M., Jimenez, C., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2367 · Cited by 101
Self-citationOperative management for recurrent and metastatic adrenocortical carcinoma
Datrice, N., Langan, R. C., Ripley, R. T., Kemp, C. D., Steinberg, S. M., Wood, B. J., Libutti, S. K., Fojo, T., Schrump, D. S., & Avital, I. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.23015 · Cited by 100
Outcomes of adrenal cortical carcinoma in the United States
Paton, B. L., Novitsky, Y. W., Zerey, M., Harrell, A. G., Norton, H. J., Asbun, H., Kercher, K. W., & Heniford, B. T. (2006) · Surgery · doi:10.1016/j.surg.2006.07.035 · Cited by 97
Interobserver variability in medical record review: An epidemiological study of asthma
Beard, C. M., Yunginger, J. W., Reed, C. E., O’Connell, E. J., & Silverstein, M. D. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90117-6 · Cited by 75
Lack, E. E., Mulvihill, J. J., Travis, W. D., & Kozakewich, H. P. (1992) · PubMed · Cited by 65
Layde, P. M., Broste, S. K., Desbiens, N. A., Follen, M. A., Lynn, J., Reding, D. J., & Vidaillet, H. J., Jr. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00006-6 · Cited by 60
Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery
Hermsen, I. G. C., Kerkhofs, T. M. A., den Butter, G., Kievit, J., van Eijck, C. H. J., van Dijkum, E. J. M. N., & Haak, H. R. (2012) · Surgery · doi:10.1016/j.surg.2012.02.005 · Cited by 47
Varley, J. M., McGown, G., Thorncroft, M. R., Cochrane, S. M., Morrison, P., Woll, P. J., Kelsey, A. M., Mitchell, E. L. D., Boyle, J. M., Birch, J. M., et al. (1996) · PubMed · Cited by 40
Patients Who Seek A Second Opinion
Sutherland, L. R., & Verhoef, M. J. (1989) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198906000-00013 · Cited by 32
Fareau, G. G., López, A., Stava, C. J., & Vassilopoulou‐Sellin, R. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328300542a · Cited by 15
Self-citationVenkatesh (1989) · doi:10.1002/1097-0142(19890801)64:3
Cited by
Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 961
Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
Beuschlein, F., Weigel, J., Saeger, W., Kroiss, M., Wild, V., Daffara, F., Libé, R., Ardito, A., Al Ghuzlan, A., Quinkler, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3182 · Cited by 342
Vanbrabant, T., Fassnacht, M., Assie, G., & Dekkers, O. M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0450 · Cited by 91
Challenges in surgical pathology of adrenocortical tumours
Erickson, L. A. (2018) · Histopathology · doi:10.1111/his.13255 · Cited by 70
Kiseljak-Vassiliades, K., Bancos, I., Hamrahian, A., Habra, M. A., Vaidya, A., Levine, A. C., & Else, T. (2020) · Endocrine Practice · doi:10.4158/dscr-2020-0567 · Cited by 66
“The majority of patients with ACC present with locally advanced disease (34% with stage 3) or metastatic disease (26% with stage 4) (74).”
BackgroundSelf-citation
Metadata
- Authors
- Ayala-Ramirez, M., Jasim, S., Feng, L., Ejaz, S., Deniz, F., Busaidy, N., Waguespack, S. G., Naing, A., Sircar, K., Wood, C. G., Pagliaro, L., Jimenez, C., Vassilopoulou-Sellin, R., & Habra, M. A.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12
- Volume
- 169
- Issue
- 6
- Pages
- 891-899
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2130168144
- Cited by
- 293
- References
- 56
- FWCI
- 13.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.